Lilly acquires Kelonia Therapeutics for $7 B to advance in vivo CAR-T cell therapies BioSpectrum Asia 3d BioSpectrum Asia 3d Kelonia Therapeutics Pharma Biotech All sources
Pharma giant Eli Lilly reacts to fake Mounjaro injection racket in Gurugram The Telegraph, Calcutta 3d The Telegraph, Calcutta 3d Mounjaro Tirzepatide Pharma All sources
Here's how Eli Lilly's oncology drugs are poised ahead of Q1 earnings Zacks 1d Zacks 1d Mounjaro Tirzepatide Pharma All sources
Indiana pharma company explores nuclear energy options World Nuclear News 2d World Nuclear News 2d US Nuclear Energy Nuclear Energy Pharma All sources
Teva Pharmaceuticals international v. Eli Lilly & Co. (Fed. Cir. 2026) JD Supra 4d JD Supra 4d Teva Patent Law Pharma All sources
Will Eli Lilly's new GLP-1 pill get the stock get back to a $1 trillion valuation? The Motley Fool 4d The Motley Fool 4d Ozempic FDA Pharma All sources
Is Eli Lilly Stock Actually ... Cheap? The Surprising Math Behind Its 2026 Valuation. The Motley Fool 21:02 Wed, 22 Apr
Pharma giant Eli Lilly reacts to fake Mounjaro injection racket in Gurugram The Telegraph, Calcutta 02:36 Wed, 22 Apr
Eli Lilly can proceed with lawsuit against telehealth seller of weight-loss drugs Courthouse News 22:24 Tue, 21 Apr
Eli Lilly’s Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analysts Proactive Investors (US) 21:06 Tue, 21 Apr